|
1
|
Duffy MJ, McGowan PM and Gallagher WM:
Cancer invasion and metastasis: changing views. J Pathol.
214:283–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005.
|
|
3
|
Valkenburg KC, Steensma MR, Williams BO
and Zhong Z: Skeletal metastasis: treatments, mouse models, and the
Wnt signaling. Chin J Cancer. 32:380–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zerlin M, Julius MA and Kitajewski J:
Wnt/Frizzled signaling in angiogenesis. Angiogenesis. 11:63–69.
2008. View Article : Google Scholar
|
|
5
|
Nusse R, Brown A, Papkoff J, et al: A new
nomenclature for int-1 and related genes: the Wnt gene family.
Cell. 64:2311991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang-Snyder J, Miller JR, Brown JD, Lai CJ
and Moon RT: A frizzled homolog functions in a vertebrate Wnt
signaling pathway. Curr Biol. 6:1302–1306. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wong GT, Gavin BJ and McMahon AP:
Differential transformation of mammary epithelial cells by Wnt
genes. Mol Cell Biol. 4:6278–6286. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Clark CC, Cohen I, Eichstetter I, et al:
Molecular cloning of the human proto-oncogene Wnt-5A and mapping of
the gene (WNT5A) to chromosome 3p14-p21. Genomics. 18:249–260.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Danielson KG, Pillarisetti J, Cohen IR, et
al: Characterization of the complete genomic structure of the human
WNT-5A gene, functional analysis of its promoter, chromosomal
mapping, and expression in early human embryogenesis. J Biol Chem.
270:31225–31234. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
DasGupta R, Kaykas A, Moon RT and Perrimon
N: Functional genomic analysis of the Wnt-wingless signaling
pathway. Science. 308:826–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nemeth MJ, Topol L, Anderson SM, Yang Y
and Bodine DM: Wnt5a inhibits canonical Wnt signaling in
hematopoietic stem cells and enhances repopulation. Proc Natl Acad
Sci USA. 104:15436–15441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Semenov MV, Habas R, Macdonald BT and He
X: SnapShot: Noncanonical Wnt signalingpathways. Cell.
131:13782007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McDonald SL and Silver A: The opposing
roles of Wnt-5a in cancer. Br J Cancer. 101:209–214. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kurayoshi M, Oue N, Yamamoto H, Kishida M,
Inoue A, Asahara T, Yasui W and Kikuchi A: Expression of Wnt-5a is
correlated with aggressiveness of gastric cancer by stimulating
cell migration and invasion. Cancer Res. 66:10439–10448. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hanaki H, Yamamoto H, Sakane H, et al: An
anti-Wnt5a antibody suppresses metastasis of gastric cancer cells
in vivo by inhibiting receptor-mediated endocytosis. Mol Cancer
Ther. 11:298–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Zhang Y, Xu R, et al:
PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA
regulate Wnt5a-induced gastric cancer cell migration. Cell Signal.
25:447–456. 2013.
|
|
17
|
Bittner M, Meltzer P, Chen Y, et al:
Molecular classification of cutaneous malignant melanoma by gene
expression profiling. Nature. 406:536–540. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Da Forno PD, Pringle JH, Hutchinson P, et
al: WNT5A expression increases during melanoma progression and
correlates with outcome. Clin Cancer Res. 14:5825–5832.
2008.PubMed/NCBI
|
|
19
|
Grossmann AH, Yoo JH, Clancy J, et al: The
small GTPase ARF6 stimulates β-catenin transcriptional activity
during WNT5A-mediated melanoma invasion and metastasis. Sci Signal.
6:ra142013.
|
|
20
|
Michl P, Ramjaun AR, Pardo OE, et al:
CUTL1 is a target of TGF(beta) signaling that enhances cancer cell
motility and invasiveness. Cancer Cell. 7:521–532. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ripka S, König A, Buchholz M, et al: WNT5A
- target of CUTL1 and potent modulator of tumor cell migration and
invasion in pancreatic cancer. Carcinogenesis. 28:1178–1187. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schlessinger K, McManus EJ and Hall A:
Cdc42 and noncanonical Wnt signal transduction pathways cooperate
to promote cell polarity. J Cell Biol. 178:355–361. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kuss P, Kraft K, Stumm J, Ibrahim D,
Vallecillo-Garcia P, Mundlos S and Stricker S: Regulation of cell
polarity in the cartilage growth plate and perichondrium of
metacarpal elements by HOXD13 and WNT5A. Dev Biol. 385:83–93. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Witze ES, Litman ES, Argast GM, Moon RT
and Ahn NG: Wnt5a control of cell polarity and directional movement
by polarized redistribution of adhesion receptors. Science.
320:365–369. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bowerman B: Cell signaling. Wnt moves
beyond the canon. Science. 320:327–328. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dissanayake SK, Wade M, Johnson CE, et al:
The Wnt5A/protein kinase C pathway mediates motility in melanoma
cells via the inhibition of metastasis suppressors and initiation
of an epithelial to mesenchymal transition. J Biol Chem.
282:17259–17271. 2007. View Article : Google Scholar
|
|
27
|
Nomachi A, Nishita M, Inaba D, Enomoto M,
Hamasaki M and Minami Y: Receptor tyrosine kinase Ror2 mediates
Wnt5a-induced polarized cell migration by activating c-Jun
N-terminal kinase via actin-binding protein filamin A. J Biol Chem.
283:27973–27981. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oishi I, Suzuki H, Onishi N, et al: The
receptor tyrosine kinase Ror2 is involved in non-canonical
Wnt5a/JNK signalling pathway. Genes Cells. 8:645–654. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Enomoto M, Hayakawa S, Itsukushima S, et
al: Autonomous regulation of osteosarcoma cell invasiveness by
Wnt5a/Ror2 signaling. Oncogene. 28:3197–3208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang C, Rajfur Z, Borchers C, Schaller MD
and Jacobson K: JNK phosphorylates paxillin and regulates cell
migration. Nature. 424:219–223. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nomachi A, Nishita M, Inaba D, Enomoto M,
Hamasaki M and Minami Y: Receptor tyrosine kinase Ror2 mediates
Wnt5a-induced polarized cell migration by activating c-Jun
N-terminal kinase via actin-binding protein filamin A. J Biol Chem.
283:27973–27981. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Katoh M and Katoh M: STAT3-induced WNT5A
signaling loop in embryonic stem cells, adult normal tissues,
chronic persistent inflammation, rheumatoid arthritis and cancer
(Review). Int J Mol Med. 19:273–278. 2007.
|
|
34
|
Li J, Ying J, Fan Y, et al: WNT5A
antagonizes WNT/β-catenin signaling and is frequently silenced by
promoter CpG methylation in esophageal squamous cell carcinoma.
Cancer Biol Ther. 10:617–624. 2010.
|
|
35
|
Kremenevskaja N, von Wasielewski R, Rao
AS, Schöfl C, Andersson T and Brabant G: Wnt-5a has tumor
suppressor activity in thyroid carcinoma. Oncogene. 24:2144–2154.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
MacLeod RJ, Hayes M and Pacheco I: Wnt5a
secretion stimulated by the extracellular calcium-sensing receptor
inhibits defective Wnt signaling in colon cancer cells. Am J
Physiol Gastrointest Liver Physiol. 293:G403–G411. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Topol L, Jiang X, Choi H, Garrett-Beal L,
Carolan PJ and Yang Y: Wnt-5a inhibits the canonical Wnt pathway by
promoting GSK-3-independent beta-catenin degradation. J Cell Biol.
162:899–908. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jönsson M and Andersson T: Repression of
Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and
migration of mammary cells. J Cell Sci. 114:2043–2053.
2001.PubMed/NCBI
|
|
39
|
Dejmek J, Dejmek A, Säfholm A, Sjölander A
and Andersson T: Wnt-5a protein expression in primary dukes B colon
cancers identifies a subgroup of patients with good prognosis.
Cancer Res. 65:9142–9146. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li Q and Chen H: Silencing of Wnt5a during
colon cancer metastasis involves histone modifications.
Epigenetics. 7:551–558. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ying J, Li H, Yu J, Ng KM, Poon FF, Wong
SC, Chan AT, Sung JJ and Tao Q: WNT5A exhibits tumor-suppressive
activity through antagonizing the Wnt/beta-catenin signaling, and
is frequently methylated in colorectal cancer. Clin Cancer Res.
14:55–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kremenevskaja N, von Wasielewski R, Rao
AS, Schöfl C, Andersson T and Brabant G: Wnt-5a has tumor
suppressor activity in thyroid carcinoma. Oncogene. 24:2144–2154.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liang H, Chen Q, Coles AH, et al: Wnt5a
inhibits B cell proliferation and functions as a tumor suppressor
in hematopoietic tissue. Cancer Cell. 4:349–360. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ying J, Li H, Chen YW, Srivastava G, Gao Z
and Tao Q: WNT5A is epigenetically silenced in hematologic
malignancies and inhibits leukemia cell growth as a tumor
suppressor. Blood. 110:4130–4132. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jönsson M, Dejmek J, Bendahl PO and
Andersson T: Loss of Wnt-5a protein is associated with early
relapse in invasive ductal breast carcinomas. Cancer Res.
62:409–416. 2002.PubMed/NCBI
|
|
46
|
Säfholm A, Tuomela J, Rosenkvist J, Dejmek
J, Härkönen P and Andersson T: The Wnt-5a-derived hexapeptide
Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell
motility. Clin Cancer Res. 14:6556–6563. 2008.PubMed/NCBI
|
|
47
|
Serra R, Easter SL, Jiang W and Baxley SE:
Wnt5a as an effector of TGFβ in mammary development and cancer. J
Mammary Gland Biol Neoplasia. 16:157–167. 2011.PubMed/NCBI
|
|
48
|
Bergenfelz C, Medrek C, Ekström E, et al:
Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and
breast cancer patients. J Immunol. 188:5448–5458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lejeune S, Huguet EL, Hamby A, Poulsom R
and Harris AL: Wnt5a cloning, expression, and up-regulation in
human primary breast cancers. Clin Cancer Res. 1:215–222.
1995.PubMed/NCBI
|
|
50
|
Kikuchi A and Yamamoto H: Tumor formation
due to abnormalities in the beta-catenin-independent pathway of Wnt
signaling. Cancer Sci. 99:202–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Leek RD and Harris AL: Tumor-associated
macrophages in breast cancer. J Mammary Gland Biol Neoplasia.
7:177–189. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nishita M, Enomoto M, Yamagata K and
Minami Y: Cell/tissue-tropic functions of Wnt5a signaling in normal
and cancer cells. Trends Cell Biol. 20:346–354. 2010. View Article : Google Scholar : PubMed/NCBI
|
